Bionano Genomics Inc. (BNGO)
NASDAQ: BNGO
· Real-Time Price · USD
1.71
-0.05 (-2.84%)
At close: Sep 25, 2025, 3:59 PM
1.73
1.13%
After-hours: Sep 25, 2025, 05:17 PM EDT
-2.84% (1D)
| Bid | 1.69 |
| Market Cap | 5.75M |
| Revenue (ttm) | 27.43M |
| Net Income (ttm) | -74.33M |
| EPS (ttm) | -43.87 |
| PE Ratio (ttm) | -0.04 |
| Forward PE | -0.47 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1.73 |
| Volume | 542,367 |
| Avg. Volume (20D) | 511,125 |
| Open | 1.77 |
| Previous Close | 1.76 |
| Day's Range | 1.68 - 1.77 |
| 52-Week Range | 1.50 - 30.60 |
| Beta | 2.26 |
| Ex-Dividend Date | n/a |
About BNGO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BNGO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BNGO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBionano Genomics Inc. is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-35.74%
Bionano Genomics shares are trading lower after th...
Unlock content with
Pro Subscription
1 week ago
-28.61%
BNGO stock has given up its prior gain. Bionano Laboratories shares were trading higher after the company announced that Centers for Medicare & Medicaid Services posted the preliminary payment determination for the Category I Current Procedural Terminology code for use of OGM in cytogenomic genome-wide analysis to detect structural and copy number variations related to constitutional genetic disorders.
